• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的血栓形成危险因素和肝脏组织学病变。

Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.

机构信息

2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital of Athens, Athens, Greece.

出版信息

J Hepatol. 2009 Nov;51(5):931-8. doi: 10.1016/j.jhep.2009.06.023. Epub 2009 Aug 3.

DOI:10.1016/j.jhep.2009.06.023
PMID:19726097
Abstract

BACKGROUND/AIMS: The pathogenetic mechanisms of development of non-alcoholic steatohepatitis (NASH) and fibrosis are not clear, although thrombosis of small intrahepatic veins has been suggested to trigger liver tissue remodelling and thrombotic risk factors have been associated with more advanced fibrosis in chronic viral hepatitis (CVH). We evaluated the prevalence of thrombotic risk factors (RFs) in non-alcoholic fatty liver disease (NAFLD) and their possible association with fatty liver or NASH.

METHODS

We included 60 patients with histologically documented NAFLD and a historical cohort of 90 patients with chronic hepatitis B (n=39) or C (n=51). Thrombophilic factors were evaluated on the day of the liver biopsy.

RESULTS

One or more thrombotic RFs were detected in 37% of NAFLD patients, and >or= 2 RFs were detected in 12% of NAFLD patients, being less frequently present than in CVH patients (37% and 68%, respectively; P <or= 0.001). Among NAFLD cases, one or more thrombotic RFs were significantly more frequently present in NASH than simple fatty liver (56% vs. 8%; odds ratio [OR]: 13.8, 2.8-67.4, P<0.001). In multivariate analysis, NASH was independently associated with moderate to severe steatosis (adjusted OR: 24.3; P=0.001) and the presence of one or more thrombotic RFs (adjusted OR: 38.7; P=0.002). Fibrosis stage was worse in NASH patients with than without thrombotic RFs (2.5+/-1.1 vs. 1.3+/-1.1; P=0.002).

CONCLUSIONS

Thrombotic RFs are frequently present in patients with NAFLD and are associated with NASH and more advanced fibrosis. Such an association may have significant clinical implications, even though it is not clear yet whether it represents a primary or secondary phenomenon.

摘要

背景/目的:非酒精性脂肪性肝炎(NASH)和纤维化的发病机制尚不清楚,尽管已经提出小的肝内静脉血栓形成可能触发肝组织重塑,并且血栓形成危险因素与慢性病毒性肝炎(CVH)中的更严重纤维化有关。我们评估了非酒精性脂肪性肝病(NAFLD)中血栓形成危险因素(RFs)的患病率及其与脂肪肝或 NASH 的可能关联。

方法

我们纳入了 60 名经组织学证实的 NAFLD 患者和一个历史队列的 90 名慢性乙型肝炎(n=39)或丙型肝炎(n=51)患者。在肝活检当天评估血栓形成因子。

结果

37%的 NAFLD 患者检测到一种或多种血栓形成 RFs,12%的 NAFLD 患者检测到>或=2 种 RFs,比 CVH 患者(分别为 37%和 68%;P<0.001)少。在 NAFLD 病例中,NASH 比单纯性脂肪肝更频繁地存在一种或多种血栓形成 RFs(56% vs. 8%;优势比[OR]:13.8,2.8-67.4,P<0.001)。在多变量分析中,NASH 与中重度脂肪变性(调整后的 OR:24.3;P=0.001)和一种或多种血栓形成 RFs 的存在(调整后的 OR:38.7;P=0.002)独立相关。有血栓形成 RFs 的 NASH 患者的纤维化分期比没有血栓形成 RFs 的患者更差(2.5+/-1.1 vs. 1.3+/-1.1;P=0.002)。

结论

血栓形成 RFs 在 NAFLD 患者中频繁出现,与 NASH 和更严重的纤维化相关。这种关联可能具有重要的临床意义,尽管尚不清楚它是原发性还是继发性现象。

相似文献

1
Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的血栓形成危险因素和肝脏组织学病变。
J Hepatol. 2009 Nov;51(5):931-8. doi: 10.1016/j.jhep.2009.06.023. Epub 2009 Aug 3.
2
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.瞬时弹性成像技术用于检测非酒精性脂肪性肝病和慢性病毒性肝炎纤维化的可靠性。
J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.
3
Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.伴有非酒精性脂肪性肝病/非酒精性脂肪性肝炎的丙型肝炎病毒相关肝硬化中的肝细胞癌的特殊组织学变异型:脂肪性肝炎相关肝细胞癌。
Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.
4
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.病态肥胖的肝脏组织病理学:其他形式慢性肝病的并发情况。
Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392.
5
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.慢性肝病患者血清脂肪因子水平:抵抗素水平与肝纤维化严重程度的关联
Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387.
6
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.代谢综合征与慢性病毒性肝炎和非酒精性脂肪性肝炎中的严重肝纤维化相关。
Aliment Pharmacol Ther. 2008 Jan 1;27(1):80-9. doi: 10.1111/j.1365-2036.2007.03538.x. Epub 2007 Oct 5.
7
Impact of non-alcoholic fatty liver disease on chronic hepatitis B.非酒精性脂肪性肝病对慢性乙型肝炎的影响。
Liver Int. 2007 Jun;27(5):607-11. doi: 10.1111/j.1478-3231.2007.01482.x.
8
Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.病态肥胖患者非酒精性脂肪性肝炎和肝纤维化进展的预测因素
Obes Surg. 2005 Mar;15(3):310-5. doi: 10.1381/0960892053576820.
9
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.葡萄糖耐量异常是非酒精性脂肪性肝病患者脂肪性肝炎和肝纤维化的一个预测指标。
Scand J Gastroenterol. 2005 Dec;40(12):1469-77. doi: 10.1080/00365520500264953.
10
Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.慢性丙型肝炎患者中非酒精性脂肪性肝炎存在的相关因素。
Am J Gastroenterol. 2005 May;100(5):1091-8. doi: 10.1111/j.1572-0241.2005.41059.x.

引用本文的文献

1
No evidence of association between inherited thrombophilia and increased risk of liver fibrosis.没有证据表明遗传性血栓形成倾向与肝纤维化风险增加之间存在关联。
United European Gastroenterol J. 2023 Dec;11(10):1010-1020. doi: 10.1002/ueg2.12500. Epub 2023 Nov 28.
2
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?肝硬化患者的门静脉血栓形成:出了什么问题?
Int J Gen Med. 2023 Aug 28;16:3889-3906. doi: 10.2147/IJGM.S413438. eCollection 2023.
3
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.
非酒精性脂肪性肝病相关的凝血与内皮功能障碍:现状与治疗意义
J Clin Transl Hepatol. 2022 Apr 28;10(2):339-355. doi: 10.14218/JCTH.2021.00268. Epub 2022 Jan 12.
4
Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis.纤溶酶原激活物抑制剂在伴有失代偿性 NASH 肝硬化的肝移植受者中显著升高。
BMJ Open Gastroenterol. 2021 Jul;8(1). doi: 10.1136/bmjgast-2021-000683.
5
Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH.非酒精性脂肪性肝炎血栓形成的健身干预(NASHFit):一项关于监督有氧运动计划以降低非酒精性脂肪性肝炎患者凝血风险升高的随机对照试验的研究方案。
Contemp Clin Trials Commun. 2020 Apr 4;18:100560. doi: 10.1016/j.conctc.2020.100560. eCollection 2020 Jun.
6
Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?非酒精性脂肪性肝病——存在血栓形成倾向?
Curr Pharm Des. 2020;26(10):1036-1044. doi: 10.2174/1381612826666200131101553.
7
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease.肝病患者静脉血栓栓塞症预防的有效性
World J Hepatol. 2019 Apr 27;11(4):379-390. doi: 10.4254/wjh.v11.i4.379.
8
Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.根据冠状动脉斑块形态评估肝脂肪变的临床意义:应用受控衰减参数。
J Gastroenterol. 2019 Mar;54(3):271-280. doi: 10.1007/s00535-018-1516-5. Epub 2018 Oct 4.
9
Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis.非酒精性脂肪性肝炎所致肝硬化住院患者静脉血栓栓塞风险增加。
Clin Transl Gastroenterol. 2018 Mar 6;9(3):140. doi: 10.1038/s41424-018-0002-y.
10
Thrombin promotes diet-induced obesity through fibrin-driven inflammation.凝血酶通过纤维蛋白驱动的炎症促进饮食诱导的肥胖。
J Clin Invest. 2017 Aug 1;127(8):3152-3166. doi: 10.1172/JCI92744. Epub 2017 Jul 24.